KMX
43
-3
CHD
48
-2
UAL
82
-4
EXPE
70
-7
NOC
40
8
MDLZ
36
-2
MO
63
12
AMZN
51
-6
AVGO
27
-8
SYY
41
2
EA
54
2
GRMN
70
-4
TXT
50
-3
SE
50
-2
GM
72
6
SWKS
33
-3
FLR
55
-3
WMT
58
2
PWR
56
-4
AAL
42
-8
KMX
43
-3
CHD
48
-2
UAL
82
-4
EXPE
70
-7
NOC
40
8
MDLZ
36
-2
MO
63
12
AMZN
51
-6
AVGO
27
-8
SYY
41
2
EA
54
2
GRMN
70
-4
TXT
50
-3
SE
50
-2
GM
72
6
SWKS
33
-3
FLR
55
-3
WMT
58
2
PWR
56
-4
AAL
42
-8
Financhill
Back

Outlook Therapeutics Vs. Brainstorm Cell Therapeutics Industry Stock Comparison

Sell
25

OTLK
Outlook Therapeutics

Last Price:
6.05
Seasonality Move:
-12.63%
Sell
7

BCLI
Brainstorm Cell Therapeutics

Last Price:
1.86
Seasonality Move:
2.27%
Sell
25
Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

  • The current Outlook Therapeutics [OTLK] share price is $5.75. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
7
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

  • The Outlook Therapeutics share price today is $5.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OTLK is experiencing slight selling pressure.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.

OTLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 53.97 Buy
Chaikin Money Flow: -24041 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.11 - 5.61) Buy
Bollinger Bands (100): (5.79 - 8.01) Sell

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 30.53 Sell
Chaikin Money Flow: -6697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2.88) Sell
Bollinger Bands (100): (2.96 - 5.76) Sell

OTLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.58 Buy
20-day SMA: 5.34 Buy
50-day SMA: 6.11 Sell
200-day SMA: 7.54 Sell
8-day EMA: 5.61 Buy
20-day EMA: 5.55 Buy
50-day EMA: 6 Sell
200-day EMA: 8.18 Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.97 Sell
20-day SMA: 2.11 Sell
50-day SMA: 3.3 Sell
200-day SMA: 5.56 Sell
8-day EMA: 1.99 Sell
20-day EMA: 2.27 Sell
50-day EMA: 3.11 Sell
200-day EMA: 6.38 Sell

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.

Outlook Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):